skip to content

Valcyte® (valganciclovir) tablets

Pharmaceutical Product Information

Valcyte® (valganciclovir) tablets

In September 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Valcyte 450 mg tablet to Pharmaco (Australia) Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Valcyte are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/

Solutions

Pharma Products
See all Pharma Products